PMCTPharmaCountry
    Accueil

Actualités réglementaires

Évolutions réglementaires FDA, EMA, TGA et mondiales

#Ranitidine ×

UPDATED
Actualités réglementaires
17 sept. 2026•1 min de lecture
FDA Approves ANDA077824 for Ranitidine Tablets by Amneal Pharmaceuticals
The FDA has granted approval for ANDA077824, authorizing Amneal Pharmaceuticals’ oral ranitidine tablets in 150 mg and 300 mg strengths, now listed as discontinued.
UPDATED
Actualités réglementaires
30 août 2026•1 min de lecture
FDA Approves Ranitidine Oral Syrup (ANDA077405)
The FDA has granted approval for ANDA077405, an oral Ranitidine hydrochloride syrup (15 mg/ml) manufactured by Pharmaceutical Associates, Inc., with labeling updates through 2010.
2